{"log_id": 2468457698178502916, "direction": 0, "words_result_num": 63, "words_result": [{"probability": {"variance": 0.003532, "average": 0.976578, "min": 0.765523}, "location": {"width": 222, "top": 4, "height": 22, "left": 555}, "words": "现血恶液质或感染征兆(比如持"}, {"probability": {"variance": 0.006736, "average": 0.931504, "min": 0.728309}, "location": {"width": 217, "top": 24, "height": 21, "left": 551}, "words": "发热、咽喉痛、淤血、出血、苍白"}, {"probability": {"variance": 1e-06, "average": 0.998796, "min": 0.996801}, "location": {"width": 99, "top": 20, "height": 21, "left": 821}, "words": "哺乳期的使用"}, {"probability": {"variance": 7e-06, "average": 0.998287, "min": 0.993545}, "location": {"width": 69, "top": 38, "height": 21, "left": 273}, "words": "变态反应"}, {"probability": {"variance": 0.001654, "average": 0.988037, "min": 0.830734}, "location": {"width": 234, "top": 46, "height": 21, "left": 546}, "words": "的患者,应立即寻求医疗指导。以上"}, {"probability": {"variance": 0.000747, "average": 0.988256, "min": 0.896678}, "location": {"width": 199, "top": 46, "height": 24, "left": 854}, "words": "尚未建立哺乳期妇女使用本品"}, {"probability": {"variance": 0.013174, "average": 0.948956, "min": 0.604738}, "location": {"width": 201, "top": 64, "height": 21, "left": 306}, "words": "常有报道与本品使用相关的变"}, {"probability": {"variance": 4e-05, "average": 0.997045, "min": 0.973831}, "location": {"width": 235, "top": 66, "height": 23, "left": 545}, "words": "患者应当立即进行包括全血细胞计数"}, {"probability": {"variance": 0.008115, "average": 0.967737, "min": 0.648617}, "location": {"width": 232, "top": 67, "height": 23, "left": 820}, "words": "的安全性。有报道本品皮下注射后"}, {"probability": {"variance": 0.011338, "average": 0.966422, "min": 0.571228}, "location": {"width": 228, "top": 83, "height": 22, "left": 278}, "words": "态反应。变态反应包括血管性水肿"}, {"probability": {"variance": 0.003833, "average": 0.978948, "min": 0.744741}, "location": {"width": 236, "top": 87, "height": 23, "left": 547}, "words": "在内的检查;如果确诊血恶液质,必"}, {"probability": {"variance": 0.00071, "average": 0.986574, "min": 0.900016}, "location": {"width": 229, "top": 89, "height": 21, "left": 821}, "words": "可从人的乳汁中分泌。皮下注射给"}, {"probability": {"variance": 0.000117, "average": 0.992396, "min": 0.963615}, "location": {"width": 233, "top": 105, "height": 23, "left": 273}, "words": "和荨麻疹,严重的此类反应曾有发"}, {"probability": {"variance": 0.026696, "average": 0.92329, "min": 0.524279}, "location": {"width": 103, "top": 109, "height": 19, "left": 547}, "words": "须停止使用本品"}, {"probability": {"variance": 4e-06, "average": 0.998277, "min": 0.993898}, "location": {"width": 231, "top": 109, "height": 22, "left": 821}, "words": "予哺乳期大鼠后,本品可以通过乳汁"}, {"probability": {"variance": 0.024054, "average": 0.944795, "min": 0.384447}, "location": {"width": 231, "top": 127, "height": 19, "left": 274}, "words": "生如果出现任何重度的变态或过"}, {"probability": {"variance": 0, "average": 0.999293, "min": 0.998592}, "location": {"width": 132, "top": 133, "height": 21, "left": 545}, "words": "中枢神经系统疾病"}, {"probability": {"variance": 0.006372, "average": 0.967184, "min": 0.680589}, "location": {"width": 230, "top": 131, "height": 21, "left": 822}, "words": "排泄,且可以在胎仔血清中检测到本"}, {"probability": {"variance": 4.9e-05, "average": 0.995829, "min": 0.973086}, "location": {"width": 233, "top": 146, "height": 25, "left": 273}, "words": "敏反应,必须立即停止使用本品并"}, {"probability": {"variance": 0.000212, "average": 0.993089, "min": 0.94335}, "location": {"width": 204, "top": 159, "height": 21, "left": 576}, "words": "罕见报告本品治疗的患者出现"}, {"probability": {"variance": 0.011481, "average": 0.963288, "min": 0.554578}, "location": {"width": 234, "top": 152, "height": 22, "left": 819}, "words": "品。由于许多药物和免疫球蛋白可由"}, {"probability": {"variance": 0.000529, "average": 0.988629, "min": 0.932725}, "location": {"width": 104, "top": 167, "height": 23, "left": 277}, "words": "进行适当的治疗"}, {"probability": {"variance": 0.000155, "average": 0.991936, "min": 0.958893}, "location": {"width": 235, "top": 179, "height": 21, "left": 545}, "words": "中枢神经系统脱髓鞘病变(参见不"}, {"probability": {"variance": 0.020145, "average": 0.942729, "min": 0.549258}, "location": {"width": 219, "top": 173, "height": 21, "left": 833}, "words": "乳汁分泌:因此哺乳期妇女需考虑"}, {"probability": {"variance": 3e-06, "average": 0.998439, "min": 0.995783}, "location": {"width": 66, "top": 192, "height": 20, "left": 272}, "words": "免疫抑制"}, {"probability": {"variance": 0.000402, "average": 0.984779, "min": 0.94841}, "location": {"width": 108, "top": 198, "height": 24, "left": 545}, "words": "良反应”)。另外"}, {"probability": {"variance": 0.068816, "average": 0.84019, "min": 0.386102}, "location": {"width": 58, "top": 203, "height": 17, "left": 715}, "words": "罕见的"}, {"probability": {"variance": 3.8e-05, "average": 0.996473, "min": 0.977617}, "location": {"width": 159, "top": 194, "height": 19, "left": 820}, "words": "是否停止哺乳或停用本品"}, {"probability": {"variance": 0.007248, "average": 0.957297, "min": 0.663282}, "location": {"width": 473, "top": 217, "height": 24, "left": 302}, "words": "白于肿瘤坏死子(TNF)可周脱髓鞘性多发性神经病的报告"}, {"probability": {"variance": 0.009116, "average": 0.958371, "min": 0.631173}, "location": {"width": 228, "top": 237, "height": 23, "left": 278}, "words": "以介导炎症反应并调节细胞免疫反"}, {"probability": {"variance": 0.000915, "average": 0.984243, "min": 0.889059}, "location": {"width": 228, "top": 242, "height": 20, "left": 548}, "words": "包括格林巴利综合征,慢性炎症"}, {"probability": {"variance": 0.000941, "average": 0.978526, "min": 0.915851}, "location": {"width": 83, "top": 233, "height": 21, "left": 810}, "words": "【儿童用药】"}, {"probability": {"variance": 0.002689, "average": 0.97974, "min": 0.791371}, "location": {"width": 221, "top": 258, "height": 20, "left": 272}, "words": "应,所以TNF抑制剂(包括本品"}, {"probability": {"variance": 0.003348, "average": 0.976745, "min": 0.764597}, "location": {"width": 234, "top": 261, "height": 23, "left": 544}, "words": "性脱髓鞘性多发性神经病,脱髓鞘"}, {"probability": {"variance": 6e-06, "average": 0.995857, "min": 0.992588}, "location": {"width": 49, "top": 259, "height": 20, "left": 845}, "words": "不适用"}, {"probability": {"variance": 0.008136, "average": 0.962121, "min": 0.631313}, "location": {"width": 228, "top": 279, "height": 20, "left": 273}, "words": "会影响患者对感染和恶性肿瘤的报"}, {"probability": {"variance": 0.007719, "average": 0.975532, "min": 0.646869}, "location": {"width": 232, "top": 281, "height": 24, "left": 544}, "words": "性多发性神经病和多灶性运动神经"}, {"probability": {"variance": 0.016561, "average": 0.962137, "min": 0.48083}, "location": {"width": 237, "top": 297, "height": 24, "left": 270}, "words": "抗力。在一项对49名接受本品治"}, {"probability": {"variance": 0.020809, "average": 0.926088, "min": 0.526638}, "location": {"width": 353, "top": 297, "height": 32, "left": 544}, "words": "病)。虽然还没有本品用于多发性【老年用药】"}, {"probability": {"variance": 2.5e-05, "average": 0.99767, "min": 0.980864}, "location": {"width": 216, "top": 321, "height": 20, "left": 271}, "words": "疗的类风湿关节炎患者的研究中"}, {"probability": {"variance": 0.021673, "average": 0.958275, "min": 0.427497}, "location": {"width": 230, "top": 323, "height": 21, "left": 543}, "words": "化症患者的临床试验,但其他"}, {"probability": {"variance": 0.000405, "average": 0.990777, "min": 0.919648}, "location": {"width": 201, "top": 322, "height": 28, "left": 848}, "words": "共有480名65岁及65岁以"}, {"probability": {"variance": 0.008537, "average": 0.963648, "min": 0.531474}, "location": {"width": 502, "top": 341, "height": 25, "left": 271}, "words": "无证据显示其可能抑制迟发性超敏TNF抑制剂对多发性硬化症意者的"}, {"probability": {"variance": 0.004842, "average": 0.971775, "min": 0.787746}, "location": {"width": 124, "top": 362, "height": 19, "left": 270}, "words": "反应,免疫球蛋白"}, {"probability": {"variance": 5.6e-05, "average": 0.99584, "min": 0.970381}, "location": {"width": 215, "top": 345, "height": 26, "left": 832}, "words": "的类风湿关节炎患者参加了本品"}, {"probability": {"variance": 4.4e-05, "average": 0.994794, "min": 0.983504}, "location": {"width": 63, "top": 363, "height": 19, "left": 441}, "words": "低或效应"}, {"probability": {"variance": 1.3e-05, "average": 0.998185, "min": 0.985822}, "location": {"width": 230, "top": 364, "height": 24, "left": 543}, "words": "临床试验显示疾病活动性有所增加"}, {"probability": {"variance": 0.000495, "average": 0.989228, "min": 0.934847}, "location": {"width": 109, "top": 381, "height": 20, "left": 270}, "words": "细胞群计数改变"}, {"probability": {"variance": 0.001172, "average": 0.983533, "min": 0.863872}, "location": {"width": 234, "top": 365, "height": 25, "left": 814}, "words": "的临床试验。在1965名银屑病患"}, {"probability": {"variance": 0.00167, "average": 0.979462, "min": 0.859058}, "location": {"width": 152, "top": 384, "height": 24, "left": 544}, "words": "当对曾经或正患有脱髓"}, {"probability": {"variance": 0.014686, "average": 0.9131, "min": 0.741719}, "location": {"width": 42, "top": 390, "height": 16, "left": 730}, "words": "病的患"}, {"probability": {"variance": 7e-06, "average": 0.998453, "min": 0.990172}, "location": {"width": 230, "top": 387, "height": 23, "left": 818}, "words": "者参与的本品和安慰剂对照随机临"}, {"probability": {"variance": 0.013857, "average": 0.955018, "min": 0.493578}, "location": {"width": 468, "top": 404, "height": 22, "left": 306}, "words": "当患者明显泰露于水痘一带状者或者被认为可能增加出现脱髓鞘"}, {"probability": {"variance": 0.001288, "average": 0.987185, "min": 0.854118}, "location": {"width": 232, "top": 406, "height": 25, "left": 814}, "words": "床试验中,共有138名患者超过"}, {"probability": {"variance": 0.00022, "average": 0.991461, "min": 0.952799}, "location": {"width": 231, "top": 423, "height": 20, "left": 271}, "words": "疱疹病毒时应暂停使用本品,并应"}, {"probability": {"variance": 0.009557, "average": 0.966112, "min": 0.602227}, "location": {"width": 230, "top": 427, "height": 22, "left": 544}, "words": "疾病风险的患者开立处方时,应連"}, {"probability": {"variance": 0.000594, "average": 0.989457, "min": 0.903243}, "location": {"width": 232, "top": 442, "height": 25, "left": 268}, "words": "考虑使用水痘一带状疱疹免疫球蛋"}, {"probability": {"variance": 0.008177, "average": 0.954639, "min": 0.722762}, "location": {"width": 229, "top": 426, "height": 27, "left": 817}, "words": "65岁,未观察到银屑病老年患者"}, {"probability": {"variance": 0.000531, "average": 0.991666, "min": 0.909273}, "location": {"width": 217, "top": 447, "height": 24, "left": 542}, "words": "议进行包括神经系统评估在内的"}, {"probability": {"variance": 0.01496, "average": 0.95716, "min": 0.508932}, "location": {"width": 228, "top": 447, "height": 27, "left": 813}, "words": "和年轻患者在安全性和疗效方面自"}, {"probability": {"variance": 1.2e-05, "average": 0.996854, "min": 0.988419}, "location": {"width": 124, "top": 467, "height": 20, "left": 539}, "words": "细风险/受益评估"}, {"probability": {"variance": 0.000283, "average": 0.994661, "min": 0.93178}, "location": {"width": 232, "top": 468, "height": 25, "left": 814}, "words": "差异,但是参与银屑病临床试验的"}, {"probability": {"variance": 0.019299, "average": 0.655707, "min": 0.516787}, "location": {"width": 38, "top": 1083, "height": 117, "left": 885}, "words": "圣吧"}], "language": 3}